Halil Ateş

498 total citations
31 papers, 368 citations indexed

About

Halil Ateş is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Halil Ateş has authored 31 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Hematology and 7 papers in Immunology. Recurrent topics in Halil Ateş's work include Platelet Disorders and Treatments (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Erythrocyte Function and Pathophysiology (3 papers). Halil Ateş is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Erythrocyte Function and Pathophysiology (3 papers). Halil Ateş collaborates with scholars based in Türkiye and United States. Halil Ateş's co-authors include Sefa Kızıldağ, Servet Kızıldağ, Mehmet Ali Özcan, Fatih Demırkan, Hilal Koçdor, Mehmet Ali Koçdor, Hale Ören, Neşe Atabey, Şermin Genç and Tuğba Yavuzşen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Halil Ateş

29 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Halil Ateş Türkiye 12 114 90 82 51 50 31 368
Haruka Iwao Japan 12 104 0.9× 99 1.1× 139 1.7× 49 1.0× 34 0.7× 22 472
Panagiota Matsouka Greece 10 119 1.0× 97 1.1× 70 0.9× 58 1.1× 19 0.4× 23 369
V Deutsch Israel 11 81 0.7× 104 1.2× 67 0.8× 70 1.4× 26 0.5× 19 423
Michiaki Hirayama Japan 14 92 0.8× 123 1.4× 169 2.1× 26 0.5× 29 0.6× 56 575
Johanna W.A.M. Celie Netherlands 12 144 1.3× 75 0.8× 32 0.4× 67 1.3× 24 0.5× 13 463
Fulya Öz Puyan Türkiye 14 158 1.4× 31 0.3× 87 1.1× 44 0.9× 90 1.8× 70 567
Tomoyuki Shirase Japan 10 173 1.5× 38 0.4× 40 0.5× 29 0.6× 36 0.7× 32 436
Elizabeth A. McCart United States 12 114 1.0× 39 0.4× 34 0.4× 34 0.7× 23 0.5× 17 384
Leszek Kraj Poland 12 111 1.0× 36 0.4× 100 1.2× 47 0.9× 15 0.3× 32 393
Alice Barinotti Italy 10 88 0.8× 85 0.9× 21 0.3× 46 0.9× 26 0.5× 36 325

Countries citing papers authored by Halil Ateş

Since Specialization
Citations

This map shows the geographic impact of Halil Ateş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halil Ateş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halil Ateş more than expected).

Fields of papers citing papers by Halil Ateş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halil Ateş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halil Ateş. The network helps show where Halil Ateş may publish in the future.

Co-authorship network of co-authors of Halil Ateş

This figure shows the co-authorship network connecting the top 25 collaborators of Halil Ateş. A scholar is included among the top collaborators of Halil Ateş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Halil Ateş. Halil Ateş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ateş, Halil, et al.. (2023). Does Combination of DNR and Casticin show advantage in favor of apoptosis on AML leukemia stem-like cell lines? A preliminary study. Journal of Research in Pharmacy. 27(3)(27(3)). 1270–1288. 1 indexed citations
2.
3.
Açıkgöz, Eda, et al.. (2020). Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells. PLoS ONE. 15(2). e0229104–e0229104. 22 indexed citations
4.
5.
Koçdor, Hilal, et al.. (2015). Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer. Drug Design Development and Therapy. 9. 3899–3899. 38 indexed citations
6.
Alacacıoğlu, İnci, et al.. (2014). Mast cell leukemia associated with undefined morphology and chronic basophilic leukemia. PubMed. 14(1). 17–17. 4 indexed citations
7.
Ateş, Halil, et al.. (2013). New paraneoplastic syndrome in chronic basophilic leukemia. International Journal of Hematology. 97(4). 498–504. 3 indexed citations
8.
Sarı, İ̇smail, Giray Bozkaya, Ahmet Alacacıoğlu, et al.. (2012). Evaluation of Circulating Endothelial and Platelet Microparticles in Men with Ankylosing Spondylitis. The Journal of Rheumatology. 39(3). 594–599. 19 indexed citations
9.
Aktaş, Safiye, et al.. (2011). The correlation between T regulatory cells and autologous peripheral blood stem cell transplantation in multiple myeloma. SHILAP Revista de lepidopterología. 28(2). 107–114. 2 indexed citations
10.
11.
Altun, Zekiye, et al.. (2010). Discrimination Effectiveness of CK18 on Cell Death Modes in Colon Cancer Cells. 1 indexed citations
12.
Kızıldağ, Sefa, Halil Ateş, & Servet Kızıldağ. (2009). Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21. Annals of Hematology. 89(1). 1–7. 59 indexed citations
13.
Akarsu, Mesut, et al.. (2007). Reticulated platelet levels in patients with ulcerative colitis. International Journal of Colorectal Disease. 22(12). 1429–1435. 29 indexed citations
14.
Genç, Şermin, et al.. (2007). 99mTc-HMPAO labelling inhibits cell motility and cell proliferation and induces apoptosis of NC–NC cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 631(2). 69–76. 3 indexed citations
15.
Sercan, Hakki Ogün, et al.. (2007). Induction of apoptosis increases expression of non-canonical WNT genes in myeloid leukemia cell lines. Oncology Reports. 18(6). 1563–9. 9 indexed citations
16.
Vural, Filiz, Mehmet Ali Özcan, Güner Hayri Özsan, et al.. (2005). Cyclo-oxygenase 2 inhibitor, nabumetone, inhibits proliferation in chronic myeloid leukemia cell lines. Leukemia & lymphoma. 46(5). 753–756. 5 indexed citations
17.
Genç, Şermin, et al.. (2003). Interferon gamma and lipopolysaccharide upregulate TNF-related apoptosis-inducing ligand expression in murine microglia. Immunology Letters. 85(3). 271–274. 21 indexed citations
18.
Uçar, Canan, Hale Ören, Halil Ateş, et al.. (2003). Investigation of megakaryocyte apoptosis in children with acute and chronic idiopathic thrombocytopenic purpura. European Journal Of Haematology. 70(6). 347–352. 17 indexed citations
19.
Vural, Filiz, Mehmet Ali Özcan, Fatih Demırkan, et al.. (2003). Gingival Involvement in a Patient with CD56+Chronic Myelomonocytic Leukemia. Leukemia & lymphoma. 45(2). 415–418. 10 indexed citations
20.
Ören, Hale, Gülersu İrken, Halil Ateş, et al.. (2003). Neutrophil Apoptosis in Patients with β-Thalassemia Major. Pediatric Hematology and Oncology. 20(3). 237–243. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haruka Iwao Breakdown of academic impact, for papers by Panagiota Matsouka Breakdown of academic impact, for papers by V Deutsch Breakdown of academic impact, for papers by Michiaki Hirayama Breakdown of academic impact, for papers by Johanna W.A.M. Celie Breakdown of academic impact, for papers by Fulya Öz Puyan Breakdown of academic impact, for papers by Tomoyuki Shirase Breakdown of academic impact, for papers by Elizabeth A. McCart Breakdown of academic impact, for papers by Leszek Kraj Breakdown of academic impact, for papers by Alice Barinotti
Rankless by CCL
2026